Novel therapeutic approaches for COVID-19 in chronic kidney disease and transplant.
Document Type
Article
Publication Date
1-2021
Publication Title
Current Opinion in Nephrology and Hypertension
Abstract
PURPOSE OF REVIEW: Severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2) is the novel virus responsible for the current worldwide pandemic. The scientific and healthcare communities have made every effort to discover and implement treatment options at a historic pace. Patients with kidney disease are uniquely vulnerable to an infectious pandemic because of their need to be in frequent contact with the healthcare system for life-sustaining renal replacement therapy whether it be by dialysis or transplant.
RECENT FINDINGS: The use of targeted viral therapies, extracorporeal therapies, immunosuppressive therapy and public health interventions are important in the management of patients with COVID-19 but require special consideration in patients with kidney disease because of the complexity of their condition.
SUMMARY: Here, we discuss some of the major efforts made to prevent spread and emerging treatment options for this virus, as they pertain to patients with kidney disease.
Volume
30
Issue
1
First Page
47
Last Page
53
Recommended Citation
Ferrey AJ, Hanna R, Reddy UG, Tantisattamo E, Kalantar-Zadeh K, Amin AN. Novel therapeutic approaches for COVID-19 in chronic kidney disease and transplant. Curr Opin Nephrol Hypertens. 2021 Jan;30(1):47-53. doi: 10.1097/MNH.0000000000000671. PMID: 33186223.
DOI
10.1097/MNH.0000000000000671
ISSN
1473-6543
PubMed ID
33186223
